BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Malaguarnera G, Giordano M, Paladina I, Rando A, Uccello M, Basile F, Biondi A, Carnazzo S, Alessandria I, Mazzarino C. Markers of bile duct tumors. World J Gastrointest Oncol 2011; 3(4): 49-59 [PMID: 21528090 DOI: 10.4251/wjgo.v3.i4.49]
URL: https://www.wjgnet.com/1007-9327/full/v3/i4/49.htm
Number Citing Articles
1
Hafida Benhammane, Saoussane Kharmoum, Sylvain Terraz, Thierry Berney, Thai Nguyen-Tang, Muriel Genevay, Omar El Mesbahi, Arnaud Roth. Common bile duct adenocarcinoma in a patient with situs inversus totalis: report of a rare caseBMC Research Notes 2012; 5(1) doi: 10.1186/1756-0500-5-681
2
Ling Cheng, Ping-hua Xu, Bao-de Shen, Gang Shen, Juan-juan Li, Ling Qiu, Chao-yong Liu, Hai-long Yuan, Jin Han. Improve bile duct-targeted drug delivery and therapeutic efficacy for cholangiocarcinoma by cucurbitacin B loaded phospholipid complex modified with berberine hydrochlorideInternational Journal of Pharmaceutics 2015; 489(1-2): 148 doi: 10.1016/j.ijpharm.2015.04.024
3
Wipaporn JARUJAREET, Kensuke TAIRA, Hong Kean OOI. Dynamics of liver enzymes in rabbits experimentally infected with <i>Fasciola</i> sp. (Intermediate form from Japan)Journal of Veterinary Medical Science 2018; 80(1): 36 doi: 10.1292/jvms.17-0315
4
Krishan R. Jethwa, Christopher L. Hallemeier. Principles and Practice of Particle Therapy2022; : 311 doi: 10.1002/9781119707530.ch19
5
Michelle X. Yang, Ryan F. Coates, Abiy Ambaye, Juli-Anne Gardner, Richard Zubarick, Yuan Gao, Joan Skelly, James G. Liu, Mari Mino-Kenudson. Investigation of HNF-1B as a diagnostic biomarker for pancreatic ductal adenocarcinomaBiomarker Research 2018; 6(1) doi: 10.1186/s40364-018-0139-6
6
Ge Zhang, Shuai Gong, Lina Pang, Lixia Hou, Wei He. Efficacy and Safety of Apatinib Treatment for Advanced Cholangiocarcinoma After Failed Gemcitabine-Based Chemotherapy: An Open-Label Phase II Prospective StudyFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.659217
7
Eduardo E. Montalvo-Javé, Germán E. Mendoza Barrera, Alan I. Valderrama Treviño, María C. Piña Barba, César Montalvo-Arenas, Fernando Rojas Mendoza, Benjamin León Mancilla, Manuel A. García Pineda, Álvaro Jaime Limón, Jorge Albores Saavedra, Jesús Tapia-Jurado. Absorbable bioprosthesis for the treatment of bile duct injury in an experimental modelInternational Journal of Surgery 2015; 20: 163 doi: 10.1016/j.ijsu.2015.06.074
8
Wiphawan Wasenang, Ponlatham Chaiyarit, Siriporn Proungvitaya, Temduang Limpaiboon. Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseasesClinical Epigenetics 2019; 11(1) doi: 10.1186/s13148-019-0634-0
9
Antonio Biondi, Giulia Malaguarnera, Marco Vacante, Massimiliano Berretta, Velia D’Agata, Michele Malaguarnera, Francesco Basile, Filippo Drago, Gaetano Bertino. Elevated serum levels of Chromogranin A in hepatocellular carcinomaBMC Surgery 2012; 12(S1) doi: 10.1186/1471-2482-12-S1-S7
10
Chao Yin, Monika Kulasekaran, Tina Roy, Brennan Decker, Sonja Alexander, Mathew Margolis, Reena C. Jha, Gary M. Kupfer, Aiwu R. He. Homologous Recombination Repair in Biliary Tract Cancers: A Prime Target for PARP Inhibition?Cancers 2022; 14(10): 2561 doi: 10.3390/cancers14102561
11
Mario Uccello, Giulia Malaguarnera, Thea Corriere, Antonio Biondi, Francesco Basile, Mariano Malaguarnera. Risk of Hepatocellular Carcinoma in Workers Exposed to ChemicalsHepatitis Monthly 2012; 12(10) doi: 10.5812/hepatmon.5943
12
Michael T. Schmidt, Eric A. Himmelfarb, Hedyeh Shafi, Fan Lin, Haodong Xu, Hanlin L. Wang. Use of IMP3, S100P, and pVHL Immunopanel to Aid in the Interpretation of Bile Duct Biopsies With Atypical Histology or Suspicious for MalignancyApplied Immunohistochemistry & Molecular Morphology 2012; 20(5): 478 doi: 10.1097/PAI.0b013e318245e05b
13
Liting Wang, Jiwen Wang, Ke Gong, Qing Shen, Hao Fu, Hui Huang, Chuanrong Chen, Lin Zhang, Yourong Duan, Tao Suo. Amyloid Precursor Protein Influences Gallbladder Cancer Cell Behaviors and may be an Effective Prognostic FactorNano LIFE 2020; 10(01n02): 2040002 doi: 10.1142/S1793984420400024
14
Patutong Chatchawal, Molin Wongwattanakul, Patcharaporn Tippayawat, Nichada Jearanaikoon, Amonrat Jumniansong, Thidarat Boonmars, Patcharee Jearanaikoon, Bayden R. Wood. Monitoring the Progression of Liver Fluke-Induced Cholangiocarcinoma in a Hamster Model Using Synchrotron FTIR Microspectroscopy and Focal Plane Array Infrared ImagingAnalytical Chemistry 2020; 92(23): 15361 doi: 10.1021/acs.analchem.0c02656
15
M. Grunnet, I.J. Christensen, U. Lassen, L.H. Jensen, M. Lydolph, I.K. Lund, T. Thurison, G. Høyer-Hansen, M. Mau-Sørensen. Prognostic significance of circulating intact and cleaved forms of urokinase plasminogen activator receptor in inoperable chemotherapy treated cholangiocarcinoma patientsClinical Biochemistry 2014; 47(7-8): 599 doi: 10.1016/j.clinbiochem.2014.01.030
16
Erfan Amini, Farhad Pishgar, Asal Hojjat, Mohammad Soleimani, Majid Ali Asgari, Abdol-Mohammad Kajbafzadeh. The role of serum and urinary carbohydrate antigen 19-9 in predicting renal injury associated with ureteral stoneRenal Failure 2016; 38(10): 1626 doi: 10.1080/0886022X.2016.1202732
17
Aleksandra Lasota, Anna Wasilewska, Agnieszka Rybi-Szumińska. Current Status of Protein Biomarkers in Urolithiasis—A Review of the Recent LiteratureJournal of Clinical Medicine 2023; 12(22): 7135 doi: 10.3390/jcm12227135
18
Razieh Sangsari, Kayvan Mirnia, Maryam Saeedi, Nina Gozali Asl, Abdol-Mohammad Kajbafzadeh. Prognostic Value of Carbohydrate Antigen 19-9 in the Urine of Mothers with Fetal Hydronephrosis to the Severity and Cause of Neonatal Renal InvolvementJournal of Clinical Neonatology 2022; 11(3): 143 doi: 10.4103/jcn.jcn_6_22
19
Patricia García, Carolina Bizama, Lorena Rosa, Jaime A. Espinoza, Helga Weber, Javier Cerda-Infante, Marianela Sánchez, Viviana P. Montecinos, Justo Lorenzo-Bermejo, Felix Boekstegers, Marcela Dávila-López, Francisca Alfaro, Claudia Leiva-Acevedo, Zasha Parra, Diego Romero, Sumie Kato, Pamela Leal, Marcela Lagos, Juan Carlos Roa. Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumorBiological Research 2020; 53(1) doi: 10.1186/s40659-020-00282-7
20
Changpeng Chai, Huan Tang, Xin Miao, Tingting Chen, Yuanhui Su, Lu Li, Long Miao, Bo Zhang, Zhengfeng Wang, Wei Luo, Hui Zhang, Hao Xu, Wence Zhou. Establishment and characterization of a novel human gallbladder cancer cell line, GBC-X1Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-72830-0
21
Kensuke Terai, Meizi Jiang, Wataru Tokuyama, Takeyoshi Murano, Nobuo Takada, Kengo Fujimura, Hiroyuki Ebinuma, Toshihiko Kishimoto, Nobuyuki Hiruta, Wolfgang J. Schneider, Hideaki Bujo. Levels of soluble LR11/SorLA are highly increased in the bile of patients with biliary tract and pancreatic cancersClinica Chimica Acta 2016; 457: 130 doi: 10.1016/j.cca.2016.04.010
22
Iago Dillion Lima Cavalcanti, José Cleberson Santos Soares. Advances in Cancer Treatment2021; : 15 doi: 10.1007/978-3-030-68334-4_3
23
Eric I Marks, Matthew Brennan, Wafik S El-Deiry. Correlation of CEA but not CA 19-9 as serum biomarkers of disease activity in a case of metastatic rectal adenocarcinomaCancer Biology & Therapy 2015; 16(8): 1136 doi: 10.1080/15384047.2015.1057360
24
Giuliana Cavalloni, Caterina Peraldo-Neia, Chiara Varamo, Laura Casorzo, Carmine Dell’Aglio, Paola Bernabei, Giovanna Chiorino, Massimo Aglietta, Francesco Leone. Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patientTumor Biology 2016; 37(3): 4041 doi: 10.1007/s13277-015-4215-3
25
Daniela Fischerova. Ovarian Neoplasm Imaging2013; : 335 doi: 10.1007/978-1-4614-8633-6_22
26
Marian A. Taulescu, Pompei F. Bolfă, Rareş Buiga, Adrian F. Gal, Bogdan Sevastre, Iancu Morar, Cornel Cătoi. Metastatic cholangiocarcinoma in a llama (Lama glama)Journal of Veterinary Diagnostic Investigation 2012; 24(5): 986 doi: 10.1177/1040638712452110